Tenaya therapeutics to participate in upcoming investment conferences

South san francisco, calif., sept. 03, 2024 (globe newswire) -- tenaya therapeutics, inc. (nasdaq: tnya), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease, today announced that faraz ali, tenaya's chief executive officer, will participate in several upcoming investment conferences. details are as follows:
TNYA Ratings Summary
TNYA Quant Ranking